Core Viewpoint - The report from Haitong International indicates a rebound in investor risk appetite during the New Year period, with expectations for the consumer staples sector to follow suit, although the overall fundamentals lack catalysts [1] Demand - Among the eight key consumer sectors tracked in December, four showed positive growth while four experienced negative growth. The growing sectors included condiments, frozen foods, soft drinks, and dining, while the declining sectors included high-end and mid-range liquor, dairy products, and beer. Compared to the previous month, most sectors, except high-end liquor, saw improvements in year-on-year growth rates [2] Pricing - In December, the prices of most liquor products stabilized, with specific prices for various brands noted. For example, the price for Feitian liquor was 1600 yuan per box, down 50 yuan from the previous month and down 720 yuan year-on-year. The price for Wuliangye was 820 yuan, up 20 yuan from the previous month but down 100 yuan year-on-year [3] Cost - The cost index for six categories of consumer goods showed mixed results in December. The cost indices for soft drinks, instant noodles, condiments, dairy products, frozen foods, and beer changed by +1.06%, +0.49%, -0.29%, -0.45%, -0.54%, and -1.05% respectively. Prices for raw materials such as aluminum cans and paper saw significant year-on-year changes [4] Capital - As of the end of December, net inflows into Hong Kong Stock Connect amounted to 20.825 billion yuan, a decrease from the previous month's inflow. The market capitalization of the consumer staples sector accounted for 5.61% of the total, an increase of 0.2 percentage points from the previous month [5] Valuation - By the end of December, the historical PE ratio for A-share food and beverage sectors was at 16% (20.3x), a decrease of 5 percentage points from the previous month. The median valuation for leading food and beverage companies in A-shares remained stable at 22x [6]

Group 1 - The core viewpoint of the article is that Baidu plans to spin off its non-wholly-owned subsidiary Kunlun Chip and list it independently on the Hong Kong Stock Exchange, which is seen as a timely move to capitalize on the IPO wave of GPU suppliers [1] - According to IDC data, Kunlun Chip ranks third in terms of shipment volume with 69,000 units projected for 2024 [1] - The Chinese AI chip market is expected to grow from 142.5 billion yuan in 2025 to 1.3368 trillion yuan by 2029, reflecting a compound annual growth rate of 53.7% [1] Group 2 - Prior to the latest financing round, Baidu held a 59% stake in Kunlun Chip and is expected to maintain a 50% stake post-IPO [1] - Using the valuation benchmark of three times the valuation of Muxi, Kunlun Chip could contribute approximately $29.2 billion to Baidu's market value after applying a 40% discount; without the discount, the contribution could be around $48.7 billion [1] - Baidu's traditional business is valued at $34.7 billion, calculated based on a net profit of 24.3 billion yuan for 2026 and a price-to-earnings ratio of 10 times, leading to a total estimated market value of Baidu at approximately $64.5 billion, excluding potential value releases from Baidu's Apollo Go and other assets [1]

Core Viewpoint - Haitong International initiates coverage on Leshush with a target price of HKD 40.5 and an "Outperform" rating, indicating positive expectations for the company's future performance [1] Group 1: Business Strategy - The company is expected to replicate its existing operational model in Africa to expand into emerging markets such as Latin America, which share similar demographics and consumer attributes [1] - The focus will be on expanding product offerings in health care and hygiene-related sectors [1] Group 2: Growth Opportunities - Strategic acquisitions are anticipated to be a key method for the company to rapidly acquire brand assets and market entry [1]

Core Viewpoint - Haitong International initiates coverage on Leshushi (02698) with an "Outperform" rating and a target price of HKD 40.5, reflecting a strong growth outlook driven by its leading position in the African hygiene products market [2] Group 1: Company Overview - Leshushi is a multinational hygiene products company focused on emerging markets such as Africa, Latin America, and Central Asia, specializing in the development, manufacturing, and sales of baby diapers, baby pull-ups, sanitary napkins, and wet wipes [3] - According to Frost & Sullivan data, Leshushi ranks first in Africa's baby diaper and sanitary napkin markets by sales volume, with market shares of 20.3% and 15.6% respectively, and ranks second by revenue with market shares of 17.2% and 11.9% [3] Group 2: Growth Drivers - The combination of population growth and urbanization in Africa, along with low penetration rates of baby and female hygiene products, drives significant industry growth potential, with Leshushi showing strong growth momentum in both baby diapers and sanitary napkins [4] Group 3: Competitive Advantages - Leshushi employs a differentiated brand strategy, having developed a strong brand matrix since launching its core brand Softcare in Ghana in 2009, now encompassing over 340 SKUs across four core categories [5] - The company has established local production capabilities in eight African countries, with eight factories and 51 production lines, making it the largest local manufacturer of hygiene products in Africa, which enhances cost efficiency and consumer engagement [5] - Leshushi has a deep multi-channel sales network that reaches over 80% of the local population in key operating countries, with a presence in over 30 countries and 18 sales branches serving more than 2,800 customers [5] Group 4: Future Growth Strategy - Leshushi plans to replicate its successful "African model" in Latin America and other emerging markets to create a sustainable second growth curve [6] - The company aims to expand its product categories through channel reuse and acquisitions, transitioning from a leading hygiene products company to a leading fast-moving consumer goods group [6]

Core Viewpoint - Haitong International forecasts that Leshushi (02698) will achieve revenues of $5.5 billion, $6.5 billion, and $7.6 billion for the years 2025-2027, representing year-on-year growth of 21%, 17%, and 17% respectively. Adjusted net profits are expected to be $1.1 billion, $1.3 billion, and $1.5 billion for the same years, with year-on-year growth of 14%, 17%, and 17% respectively. Given Leshushi's leading position in the African hygiene products market and the structural opportunities from Africa's demographic dividend and increasing penetration rates, a 25x PE ratio for 2026 is suggested, corresponding to a reasonable market value of HKD 25.1 billion and a target price of HKD 40.5 [1][2]. Company Overview - Leshushi is a multinational hygiene products company focused on emerging markets such as Africa, Latin America, and Central Asia, primarily engaged in the development, manufacturing, and sales of baby diapers, pull-ups, sanitary napkins, and wet wipes. According to Frost & Sullivan data, the company ranks first in Africa's baby diaper and sanitary napkin markets by sales volume for 2024, with market shares of 20.3% and 15.6% respectively. By revenue, it ranks second in both markets, with shares of 17.2% and 11.9% respectively [2]. Growth Drivers - The combination of Africa's population growth and accelerated urbanization, along with the low penetration rates of baby and female hygiene products, drives significant industry growth potential. Leshushi demonstrates leading growth momentum in both the baby diaper and sanitary napkin markets, supported by a product matrix that covers premium, mid-range, and mass-market segments [3]. Core Competencies - Differentiated brand strategy with a strong brand matrix: Since launching its core brand Softcare in Ghana in 2009, the company has expanded to include brands such as Maya, Veesper, Cuettie, and Clincleer, creating a comprehensive brand matrix covering four core categories. As of April 2025, the company has over 340 SKUs across these categories [4]. - Localized production and supply chain management: The company initiated local production in Ghana in 2018 and has established eight factories and 51 production lines across eight African countries by April 2025, making it the hygiene products company with the most local factories in Africa. The "locally produced, locally sold" model significantly shortens the sales chain, reduces costs, and enhances consumer engagement [4]. - Extensive multi-channel sales network: As of April 2025, the sales network has expanded to over 30 countries in Africa, Latin America, and Central Asia, with 18 sales branches in 12 countries serving over 2,800 customers. The network covers all administrative regions in key operating countries, reaching over 80% of the local population [4]. Future Growth Strategy - Regional expansion: Leshushi aims to replicate its successful "African model" in Latin America and other emerging markets with similar demographics and consumption patterns, creating a sustainable second growth curve [5]. - Category expansion: The company plans to leverage existing channel networks and consumer insights to expand into health care and hygiene-related products, while also considering strategic acquisitions to rapidly gain brand assets and market entry [5].

Core Viewpoint - Haitong International initiates coverage on Geek+ (02590) with an "Outperform" rating, projecting significant growth in net profit and revenue from 2025 to 2027 [1] Financial Projections - Expected net profits for Geek+ are projected to be 137 million, 332 million, and 606 million RMB for the years 2025, 2026, and 2027 respectively [1] - Revenue forecasts for the same period are 3.13 billion, 4.03 billion, and 5.12 billion RMB [1] Business Structure and Valuation - The company has a clear main business structure and significant technological advantages [1] - Haitong International applies a price-to-sales ratio valuation, assigning a 10x price-to-sales ratio for 2026, leading to a reasonable market capitalization of 40.3 billion RMB [1] - The target price for the company is set at 32.76 HKD [1]

Core Viewpoint - Haitong International has initiated coverage on Geek+ (02590) with an "Outperform" rating, projecting significant growth in net profit and revenue from 2025 to 2027 [1] Financial Projections - The projected net profits for Geek+ from 2025 to 2027 are expected to be 137 million, 332 million, and 606 million RMB respectively [1] - The anticipated revenues for the same period are forecasted to be 3.13 billion, 4.03 billion, and 5.12 billion RMB respectively [1] Valuation and Market Position - Haitong International highlights the company's clear business structure and significant technological advantages [1] - The company is assigned a 10x price-to-sales ratio for 2026, leading to a reasonable market capitalization estimate of 40.3 billion RMB [1] - The target price for the company's stock is set at 32.76 HKD [1]

智通财经APP获悉，12月29日消息，香港证监会已撤回向三家经纪行发出的限制通知书，当中禁止它们 处置或处理特定客户账户内的款项或资产。该等账户均牵涉华瀚健康产业控股有限公司(华瀚)在财务报 表中披露虚假或具误导性的资料一事。上述三家经纪行分别是：长江证券经纪(香港)有限公司、海通国 际证券有限公司及金利丰证券有限公司。 香港证监会亦将案件转介警方商业罪案调查科跟进。警方早前以所得款项被挪用的洗钱罪，成功检控华 瀚前财务总监兼公司秘书。有鉴于此，香港证监会撤回该等限制通知书，以便BEL(现正进行清盘)的清 盘人得以向受影响人士退还受限制资产。 华瀚两名前高层人员张岳(男)及邓杰(男)名下的投资公司Bull's-Eye Limited(BEL)于该三家经纪行开设了 账户，而有关限制通知书旨在保存二人在该等账户内持有的资产。 上述三家经纪行并非香港证监会的调查对象，而该等限制通知书并不影响三者的运作或它们的其他客 户。 香港证监会经调查后揭发华瀚集资活动的所得款项曾被挪用，并发现其中有部分款项被存入BEL于上述 经纪行开立的账户内，于是采取有关行动。 ...

Company Overview - Frontera Therapeutics has submitted a listing application to the Hong Kong Stock Exchange, with UBS and Haitong International as joint sponsors [1] - The company's core business focuses on the development of innovative recombinant adeno-associated virus (rAAV) gene therapies, particularly targeting ophthalmic and cardiovascular diseases [1] - Frontera Therapeutics' product pipeline is considered to have best-in-class potential globally [1] Product Pipeline - As of December 16, 2025, Frontera Therapeutics' product pipeline includes eight self-developed rAAV gene therapy candidates [1] - The two core products are FT-002 for treating X-linked retinitis pigmentosa (XLRP) and FT-003 for treating neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME) [1] Competitive Advantages - The company possesses the AAVANCETM Bac/Sf9 production platform, which enables safe, scalable, and cost-effective high-quality production [1] - Frontera Therapeutics also has the EXACTETM proprietary rAAV gene therapy R&D platform, supporting the development of innovative products protected by global intellectual property rights [1] Regulatory Approvals - Frontera Therapeutics has received a total of 12 IND approvals from the National Medical Products Administration and the FDA, making it the company with the most IND approvals for rAAV gene therapy development in China [1] - The company has successfully advanced three candidate drugs into Phase II clinical trials [1] Industry Growth - The global gene therapy market is projected to grow from $2.8 billion in 2024 to $32 billion by 2035 [2] - The Chinese gene therapy market is also expected to experience rapid growth, reaching a market size of RMB 11.6 billion by 2035 [2]

Group 1: Foreign Brokers - Foreign brokers play a crucial role in the Hong Kong stock market as dominant players in the existing stock market, core holders of pricing power, global liquidity connectors, and providers of diversified trading strategies [1][2] - As of March 2025, international intermediaries (representing foreign capital) held a market value share of 43.38% in Hong Kong stocks, significantly higher than the Hong Kong Stock Connect (approximately 11.07%), Chinese intermediaries (8.06%), and local Hong Kong intermediaries (3.02%) [2] - The top 20 custodial brokers for Hong Kong Stock Connect, mainly large international banks like HSBC, Citibank, and Standard Chartered, account for about 90% of the holdings [3] - Foreign capital's trading behavior directly influences the valuation of core assets such as Alibaba, Tencent, and China Mobile, with foreign inflows or outflows significantly impacting stock prices [4] - The liquidity of Hong Kong stocks is highly dependent on international macroeconomic factors, particularly U.S. monetary policy, as foreign brokers are key participants in Hong Kong dollar carry trades [5] - There is a clear strategy differentiation within foreign capital, categorized into long-term funds and hedge funds, each with distinct investment behaviors and impacts on market dynamics [6][7] Group 2: Chinese Brokers - Chinese brokers, primarily funded by mainland capital, represent a growing marginal force in the Hong Kong stock market, with a market value share of approximately 14.6% from the Stock Connect and about 8% from Chinese brokerage firms [9] - There are notable internal differences in Chinese capital preferences, with Shanghai Stock Connect dominated by long-term funds like insurance, while Shenzhen Stock Connect is characterized by trading-oriented funds [10] - When foreign capital exits due to geopolitical or currency fluctuations, Southbound funds often increase their net buying, demonstrating a contrarian investment behavior [12] Group 3: Local Brokers - Local brokers in Hong Kong, such as Futu, Yau Choi, and others, currently hold an estimated market value of only 3%, primarily serving local retail and high-net-worth clients [13] - Despite their limited overall influence, local brokers play an important role in trading small-cap stocks within the local market [13] Group 4: Market Signals and Mechanisms - The Hong Kong market's "storage" and "transfer" mechanisms are central to securities custody, settlement, and cross-border trading, with most shares held indirectly through intermediaries [18] - "Storage" refers to the process of converting physical stock certificates into electronic shares for trading, which is essential for market participation [19] - Monitoring storage activities in the CCASS database can serve as a leading indicator for major shareholders' intentions to reduce holdings [22] - "Transfer" typically involves the movement of shares between brokers, which may indicate financing needs or adjustments in investment strategies [26] Group 5: Understanding Market Participants - The diverse participant structure in the Hong Kong market, from foreign banks controlling pricing power to the rising Southbound funds and local brokers, each has unique behavioral patterns and market impacts [28] - Understanding these participants' characteristics and movements can help interpret market signals and empower investors to take control in a complex market environment [28]